From: Early-onset dementias: diagnostic and etiological considerations
Prominent neurological features and disorders | Associated clinical features | Chromosome/inheritance | Protein/gene | Screening and diagnostic tests |
---|---|---|---|---|
Stroke | Â | Â | Â | Â |
CADASIL [93] | Migraine, psychiatric symptoms | 19p13.1-p13.2/autosomal dominant | Notch 3 receptor protein (NOTCH3) | Skin biopsy - granular deposits in basal lamina of small vessels; NOTCH3 mutation analysis |
Stroke, neuropathy | Â | Â | Â | Â |
Fabry disease [117] | Skin changes, renal dysfunction, eye findings, heart disease, diarrhea, vomiting and weight loss, stroke and painful peripheral neuropathy | Xq22/X-linked | α-galactosidase A (GLA) | Deficient α-galactosidase A activity in leukocytes and elevated urinary oligosaccharide (trihexoside) assay; GLA mutation analysis |
MELAS [117] | Short stature, strokes, seizures, migraine, myopathy, peripheral neuropathy, hearing loss, eye findings, cardiomyopathy and conduction abnormalities, diabetes | mtDNA/mitochondrial | Mitochondrial transfer RNA gene mutations (mtDNA tRNA) | EEG; serum and CSF lactate/pyruvate, mtDNA mutation analysis; muscle biopsy showing ragged red fibers |
Ataxia | Â | Â | Â | Â |
Gaucher disease [124] | Hepatosplenomegaly, thrombocytopenia, ataxia, anemia, bleeding, osteopenia, bone abnormalities, growth retardation | 1q21/autosomal recessive | Glucocerebrosidase (GBA1) | Deficient glucocerebrosidase activity in leukocytes; GBA1 mutation analysis |
Fragile × tremor-ataxia syndrome [125] | Tremor, ataxia, parkinsonism, peripheral neuropathy, dysautonomia | Xq27.3/X-linked | Fragile × Mental Retardation 1 (FMR1) | DNA analysis of CGG trinucleotide repeat expansion demonstrating 55 to 200 repeats (permutation range) |
Ataxia, pyramidal | Â | Â | Â | Â |
Adult-onset Tay Sach's disease/GM2 gangliosidosis [126] | Psychiatric symptoms, cerebellar, upper motor neuron, lower motor neuron, and/or extrapyramidal findings | 15q24.1/autosomal recessive | Hexosaminidase A (HEXA) | Hexosaminidase A levels; HEXA mutation screening |
Hereditary diffuse leukoencephalopathy with spheroids [127] | Depression, spasticity, ataxia, gait disorder, personality and behavior change, parkinsonism, seizures | 5q32/autosomal dominant | Colony-stimulating factor 1 receptor (CSF1R) | Frontal and parietal white matter hyperintensity on T2/FLAIR MRI; CSF1R mutation analysis |
Ataxia, chorea | Â | Â | Â | Â |
Kufs disease/adult-onset neuronal ceroid lipofuscinosis [128] | Facial dyskinesia, ataxia, extrapyramidal signs, myoclonic epilepsy, dysarthria | 1p32/autosomal recessive | Palmitoyl-protein thioesterase 1 (PPT1) in a minority; other genes unknown | Tissue biopsy demonstrating ceroid lipofuscin |
Dentatorubral-pallidoluysian atrophy [129] | Ataxia, choreoathetosis, psychiatric symptoms | 12p13.31/autosomal dominant | Atrophin-1 (ATN1) | DNA analysis of CAG trinucleotide repeat expansion demonstrating ≥48 repeats |
Ataxia, pyramidal, neuropathy | Â | Â | Â | Â |
Cerebrotendinous xanthomatosis [130] | Ataxia, peripheral neuropathy, pyramidal signs, psychiatric symptoms, seizures, cataracts, Achilles tendon xanthomas, diarrhea, osteopenia | 2q35/autosomal recessive | Sterol 26-hydroxylase, mitochondrial (CYP27A1) | Elevated serum cholestanol and serum/urine bile alcohols; CYP27A1 mutation analysis |
Adrenoleukodystrophy [131] | Behavioral change, peripheral neuropathy, myelopathy, Addison's disease | Xq28/X-linked | ATP-binding cassette transporter, subfamily D, Type 1 (ABCD1) | Evidence of dysmyelination on T2/FLAIR MRI (white matter hyperintensity in parieto-occipital, frontal or involving centrum semi-ovale or diffuse); elevated level of very long-chain fatty acids in leukocytes or fibroblasts; ABCD1 mutation analysis |
Metachromatic leukodystrophy [132] | Pyramidal signs, peripheral neuropathy, behavioral change, psychosis, ataxia, seizures, tremor | 22.q13.31-qter and 10q22.1/autosomal recessive | Aryl-sulfatase A (ARSA) or saposin B (PSAP) | Leukocyte arylsulfatase A assay; urine for elevated sulfatides; ARSA or PSAP mutation analysis |
Krabbe disease/globoid cell leukodystrophy [132] | Visual problems, gait disorder, rigidity, ataxia, pyramidal signs, peripheral neuropathy | 14q31/autosomal recessive | Galactocerebroside β-galactosidase (GALC) | Leukocyte galactocerebroside β-galactosidase; GALC mutation analysis |
Autosomal dominant spinocerebellar ataxias (SCA) [133] | Multiple subtypes with most common being: SCA1 - ataxia, pyramidal signs; SCA2 - tremor, ataxia, hyporeflexia, chorea, myoclonus, dystonia, retinal degeneration, cardiac failure; SCA3-peripheral neuropathy, parkinsonism, diplopia, ataxia, dystonia, pyramidal signs, psychiatric symptoms; SCA7 - chorea, parkinsonism, dystonia, ataxia, pyramidal signs, seizures | Multiple loci; SCA1 - 6p22.3; SCA2 - 12q24.12; SCA3 - 14q32.12. SCA7 - 3p14.1/autosomal dominant | SCA1 - Ataxin-1 (ATXN1); SCA2-Ataxin-2 (ATXN2); SCA3 - Ataxin-3 (ATXN3); SCA7-Ataxin-7 (ATXN7) | DNA analysis of CAG trinucleotide repeat expansion in relevant genes |
Ataxia, chorea, supranuclear gaze palsy | Â | Â | Â | Â |
Niemann-Pick type C [119] | Cerebellar ataxia, dysarthria, dementia, psychiatric disturbances, supranuclear gaze palsy and splenomegaly | 18q11 and 14q24.3/autosomal recessive | NPC1 and NPC2, respectively | Skin fibroblast assay for intracellular cholesterol accumulation (filipin staining); or gene mutation analysis |
Ataxia, chorea, parkinsonism | Â | Â | Â | Â |
Wilson's disease [120] | Parkinsonism, dystonia, chorea, tremor, psychosis, liver dysfunction, ocular examination for Kayser-Fleischer rings | 13q14.3/autosomal recessive | ATPase, Cu2+-transporting beta polypeptide, (ATP7B) | Screening: serum ceruloplasmin, urinary copper; brain MRI shows 'face of the giant panda' sign Confirmatory: liver biopsy and ATP7B mutation analysis |
Parkinsonism, dystonia | Â | Â | Â | Â |
Pantothenate kinase-associated neurodegeneration [134] | Dysarthria, psychiatric disturbance, rigidity, dystonia, chorea, gait disturbance | 20p13-p12.3/autosomal recessive | Pantothenate kinase 2 (PANK2) | Mutation analysis of PANK2; MRI pallidal abnormalities with decreased T2 signal intensity, compatible with iron deposits ('eye of the tiger' sign) |
Chorea | Â | Â | Â | Â |
Huntington's disease [135] | Choreoathetosis, motor impersistence, saccadic eye movements, psychiatric symptoms | 4p16.3/autosomal dominant | Huntingtin (HTT) | c trinucleotide repeat expansion demonstrating ≥36 repeats |